Financials Hexima Limited

Equities

HXL

AU0000111932

Biotechnology & Medical Research

Market Closed - Australian Stock Exchange 10:43:53 2023-12-05 pm EST Intraday chart for Hexima Limited 5-day change 1st Jan Change
0.018 AUD 0.00% -21.74% -10.00%

Valuation

Fiscal Period : June 2021 2022 2023
Capitalization 1 22,2 5,01 3,51
Enterprise Value (EV) 1 18,9 1,05 1,32
P/E ratio -2,77x -0,46x -1,83x
Yield - - -
Capitalization / Revenue 5,45x 0,86x 2,36x
EV / Revenue 4,62x 0,18x 0,89x
EV / EBITDA -2,79x -0,11x -0,68x
EV / FCF -3,82x -0,18x -1,11x
FCF Yield -26,2% -559% -89,8%
Price to Book 7,30x 1,10x 1,26x
Nbr of stocks (in thousands) 130 858 167 040 167 040
Reference price 2 0,17 0,03 0,02
Announcement Date 8/27/21 9/30/22 8/31/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period : Juni 2018 2019 2020 2021 2022 2023
Net sales 1 4,37 3,43 2,57 4,08 5,81 1,48
EBITDA 1 -1,66 -2,74 -3,37 -6,76 -9,76 -1,95
EBIT 1 -1,85 -2,91 -3,53 -6,91 -9,90 -1,96
Operating Margin -42,2% -84,9% -138% -169% -170% -132%
Earnings before Tax (EBT) 1 -1,87 -2,89 -3,63 -6,87 -10,0 -1,92
Net income 1 -1,95 -2,90 -3,63 -6,87 -10,0 -1,92
Net margin -44,6% -84,4% -141% -168% -172% -129%
EPS 2 -0,03 -0,04 -0,06 -0,06 -0,07 -0,01
Free Cash Flow 1 -1,45 -0,54 -0,71 -4,93 -5,89 -1,18
FCF margin -33,1% -15,6% -27,6% -121% -101% -79,7%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 8/21/18 9/18/19 10/6/20 8/27/21 9/30/22 8/31/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period : Juni 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 1,66 - - -
Net Cash position 1 1,92 0,35 - 3,39 3,96 2,19
Leverage (Debt/EBITDA) - - -0,49x - - -
Free Cash Flow 1 -1,45 -0,54 -0,71 -4,93 -5,89 -1,18
ROE (net income / shareholders' equity) -35,5% -90,7% -3 661% -965% -263% -52,2%
Shareholders' equity 1 5,50 3,19 0,10 0,71 3,81 3,67
ROA (Net income/ Total Assets) -15,5% -29,5% -41,4% -64,0% -64,1% -17,8%
Assets 1 12,6 9,81 8,76 10,7 15,6 10,8
Book Value Per Share 2 0,07 0,03 -0,02 0,02 0,03 0,02
Cash Flow per Share 2 0,03 0,03 0,02 0,03 0,02 0,01
Capex 1 0,01 0,00 0,00 0,00 0,00 -
Capex / Sales 0,14% 0,03% 0,07% 0,06% 0,06% -
Announcement Date 8/21/18 9/18/19 10/6/20 8/27/21 9/30/22 8/31/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer